Literature DB >> 6166703

In vitro tolerance induction of primed, IgD-negative murine spleen cells.

S M Walker, W O Weigle.   

Abstract

The above observations demonstrated induction of immunological tolerance in vitro in primed IgD-, IgG+ B cells. In these studies, addition of trinitrophenylated (TNP) turkey gammaglobulin (TGG) or TNP ovalbumin conjugates suppressed the secondary in vitro response in mice primed with TNP keyhole limpet hemocyanin (TNP-KLH). Suppression was not a reflection of a shift in kinetics of the antibody response, was not dependent on suppressor T cells, and could only be eliciate when conjugate was added within 4 h of addition of TNP-KLH moreover, preincubation of the primed spleen cells with TNP-TGG for 20 h at 37 degrees C, followed by extensive washing, was as effective in inhibiting the response to TNP-KLH as when TNP-TGG was present throughout the 5 d of culture, reflecting induction of a tolerant state. Amounts of conjugate in the concentration range that have been shown by others to tolerize immature or neonatal B cells or mature B cells that have been stripped of surface IgD were sufficient to induce tolerance. The target cells being tolerized did not bear IgD, as determined by B cell depletion and blocking procedures with anti IgD. Whether the lack of surface IgD on the primed cells contributed to the relative ease of tolerance induction was not established by these studies, but the advantages of using primed B cells to examine further the role of surface IgD in tolerance susceptibility was discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166703      PMCID: PMC2186106          DOI: 10.1084/jem.153.3.653

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  T cell dependence of B cell unresponsiveness in vitro.

Authors:  H Waldmann; A J Munro
Journal:  Eur J Immunol       Date:  1974-06       Impact factor: 5.532

2.  In vitro induction of specific unresponsiveness against the 2,4,6-trinitrophenyl determinant. I. The induction of unresponsiveness.

Authors:  J Kettman
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

Review 3.  Immunological unresponsiveness.

Authors:  W O Weigle
Journal:  Adv Immunol       Date:  1973       Impact factor: 3.543

4.  Kinetic differences in unresponsiveness of thymus and bone marrow cells.

Authors:  J M Chiller; G S Habicht; W O Weigle
Journal:  Science       Date:  1971-02-26       Impact factor: 47.728

5.  Selection of cell populations in induction of tolerance: affinity of antibody formed in partially tolerant rabbits.

Authors:  G A Theis; G W Siskind
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

6.  Genetic polymorphism of IgD-like cell surface immunoglobulin in the mouse.

Authors:  J W Goding; G W Warr; N L Warner
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

7.  Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance.

Authors:  J C Cambier; J R Kettman; E S Vitetta; J W Uhr
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

8.  Ontogeny of B-lymphocyte function. III. In vivo and in vitro studies on the ease of tolerance induction in B lymphocytes from fetal, neonatal, and adult mice.

Authors:  M R Szewczuk; G W Siskind
Journal:  J Exp Med       Date:  1977-06-01       Impact factor: 14.307

9.  Immunological tolerance in bone marrow-derived lymphocytes. 3. Tolerance induction in primed B cells by hapten conjugates of unrelated immunogenic or "nonimmunogenic" carriers.

Authors:  D H Katz; T Hamaoka; B Benacerraf
Journal:  J Exp Med       Date:  1974-06-01       Impact factor: 14.307

10.  In vitro tolerance induction of neonatal murine B cells.

Authors:  E S Metcalf; N R Klinman
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  1 in total

1.  Tolerance induction and maintenance in primed lymphocytes.

Authors:  J D Levich; W O Weigle
Journal:  Surv Immunol Res       Date:  1985
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.